Pharsight

LINDIS BIOTECH GMBH patents facing oppositions

Top patents of LINDIS BIOTECH GMBH facing oppositions at the European Patent Office (EPO).

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP3177645B1 17 Feb, 2021 Subcutaneously administered bispecific antibodies for use in the treatment of cancer Aug, 2035 10